Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of Transporters in Intestinal Drug-Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time. | Pharmaceutics | 2022 | 36432682 | PubTator, text mining | PubMed |
| Interaction of Masitinib with Organic Cation Transporters. | Int J Mol Sci | 2022 | 36430667 | PubTator, text mining | PubMed |
| Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea. | Viruses | 2022 | 36423167 | PubTator, text mining | PubMed |
| Assessment of potential drug-drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study). | Heliyon | 2022 | 36387483 | PubTator, text mining | PubMed |
| Discovery of novel eGFR-associated multiple independent signals using a quasi-adaptive method. | Front Genet | 2022 | 36386835 | PubTator, text mining | PubMed |
Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment with Polygonum capitatum Buch.-Ham. ex D. Don extracts. | Front Pharmacol | 2022 | 36386188 | PubTator, text mining | PubMed |
| A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles. | J Extracell Vesicles | 2022 | 36382606 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin. | Pharmaceutics | 2022 | 36365190 | PubTator, text mining | PubMed |
| Fabrication and Evaluation of Tubule-on-a-Chip with RPTEC/HUVEC Co-Culture Using Injection-Molded Polycarbonate Chips. | Micromachines (Basel) | 2022 | 36363953 | PubTator, text mining | PubMed |
| Atypical Substrates of the Organic Cation Transporter 1. | Biomolecules | 2022 | 36359014 | PubTator, text mining | PubMed |
| In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC-Application towards Cancer Therapeutics. | Curr Issues Mol Biol | 2022 | 36354673 | PubTator, text mining | PubMed |
| Structural basis of organic cation transporter-3 inhibition. | Nat Commun | 2022 | 36344565 | PubTator, text mining | PubMed |
| Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters. | J Pharmacol Sci | 2022 | 36344041 | PubTator, text mining | PubMed |
| Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency. | Proc Natl Acad Sci U S A | 2022 | 36343260 | PubTator, text mining | PubMed |
| Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes. | Front Immunol | 2022 | 36341411 | PubTator, text mining | PubMed |
| Examination of the Effect of Proton Pump Inhibitors on the Anticancer Activity of Oxaliplatin. | Cancer Diagn Progn | 2022 | 36340458 | PubTator, text mining | PubMed |
| Effect of Replicative Senescence on the Expression and Function of Transporters in Human Proximal Renal Tubular Epithelial Cells. | Biol Pharm Bull | 2022 | 36328499 | PubTator, text mining | PubMed |
| All the brain's a stage for serotonin: the forgotten story of serotonin diffusion across cell membranes. | Proc Biol Sci | 2022 | 36321487 | PubTator, text mining | PubMed |
| Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021. | Pharmaceutics | 2022 | 36297514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=21